C130060K24Rik Inhibitors
C130060K24Rik, a protein yet to be fully elucidated, emerges as a pivotal player in the intricate tapestry of cellular signaling pathways. Its potential entanglement with Mitogen-Activated Protein Kinase (MAPK), Phosphatidylinositol 3-Kinase–Protein Kinase B (PI3K-AKT), and c-Jun N-terminal Kinase (JNK) pathways hints at multifaceted roles, spanning cellular proliferation, survival, and responses to extracellular cues. In the cellular milieu, C130060K24Rik stands as a multifunctional regulator, orchestrating the harmonious interplay of molecular events, particularly influencing gene expression dynamics that delicately contribute to the nuanced fine-tuning of cellular processes.
Delving into the realm of potential modulators, the listed inhibitors meticulously target discrete pathways intricately associated with C130060K24Rik, opening avenues for nuanced modulation. Sorafenib and Selumetinib, esteemed MAPK inhibitors, weave a complex dance that indirectly influences the actions of C130060K24Rik, intimating at a regulatory role in the expansive landscape of cellular proliferation. Meanwhile, LY294002 and Wortmannin, poised as PI3K inhibitors, engage in an intricate dialogue with the cellular orchestra, potentially contributing to subtle shifts in cell survival mechanisms intricately linked to the elusive C130060K24Rik. JNK Inhibitor VIII and SP141, heralded JNK inhibitors, emerge as conductors orchestrating cellular responses and gene expression patterns, casting a profound impact on the multifaceted functions of C130060K24Rik. These pharmacological orchestrations collectively beckon researchers toward a deeper understanding of the potential regulatory mechanisms orchestrated by C130060K24Rik, paving the way for future explorations in the realm of cellular biology research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib inhibits RAF kinases, disrupting the MAPK pathway. Its influence on MAPK signaling can indirectly impact C130060K24Rik, potentially regulating cellular proliferation and survival. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, affecting the PI3K-AKT pathway. Its interference in this cascade may indirectly impact C130060K24Rik, contributing to alterations in cell survival mechanisms. | ||||||
JNK Inhibitor VIII | 894804-07-0 | sc-202673 | 5 mg | $267.00 | 2 | |
JNK Inhibitor VIII disrupts JNK signaling. Its influence on JNK pathways can indirectly affect C130060K24Rik, potentially regulating cellular responses and gene expression. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib targets BCR-ABL and c-KIT, disrupting related signaling. Its interference in these pathways may indirectly impact C130060K24Rik, affecting cellular signaling dynamics. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor, affecting the MAPK pathway. Its modulation of MAPK pathways may indirectly influence C130060K24Rik, suggesting a regulatory role in cellular proliferation. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $173.00 $230.00 $275.00 $332.00 | 9 | |
BKM120 is a pan-PI3K inhibitor, impacting the PI3K-AKT pathway. Its interference in this cascade may indirectly impact C130060K24Rik, contributing to alterations in cell survival mechanisms. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, disrupts JNK signaling. Its influence on JNK pathways can indirectly affect C130060K24Rik, potentially regulating cellular responses and gene expression. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363 targets AKT, disrupting the PI3K-AKT pathway. Its modulation of AKT pathways may indirectly influence C130060K24Rik, suggesting a regulatory role in cellular survival and growth. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $28.00 $80.00 $412.00 $1860.00 $2962.00 | 5 | |
Selumetinib is a MEK inhibitor, affecting the MAPK pathway. Its modulation of MAPK pathways may indirectly influence C130060K24Rik, suggesting a regulatory role in cellular proliferation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3K, affecting the PI3K-AKT pathway. Its interference in this cascade may indirectly impact C130060K24Rik, contributing to alterations in cell survival mechanisms. | ||||||